|
| 35307323 | Local Failure after Prostate SBRT Predominantly Occurs in the PI-RADS 4 or 5 Dominant Intraprostatic Lesion. | Eur Urol Oncol | 2023 |
| 37949730 | Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer. | Eur Urol Oncol | 2023 |
| 37678051 | Differential use of postoperative psychosocial and physical services among older adults with head and neck cancer. | J Geriatr Oncol | 2023 |
| 35689413 | Comprehensive review of the use of hydrogel spacers prior to radiation therapy for prostate cancer. | BJU Int | 2023 |
| 37439286 | Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer. | Head Neck | 2023 |
| 37169010 | Dosimetric Comparison of Intensity-Modulated Radiation Therapy (IMRT) and Intensity-Modulated Proton Therapy (IMPT) for a Novel Oral Tongue Avoidance Concept in Low-Risk Squamous Cell Carcinoma of the Oral Tongue. | Int J Part Ther | 2023 |
| 37099979 | Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity. | Oral Oncol | 2023 |
| 36521102 | Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline. | J Clin Oncol | 2023 |
| 36689229 | Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma. | JAMA Netw Open | 2023 |
| 36305841 | Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer. | CA Cancer J Clin | 2023 |
| 34388295 | Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicity. | BJU Int | 2022 |
| 35647395 | Peer Review of Head and Neck Cancer Planning Target Volumes in Radiation Oncology. | Adv Radiat Oncol | 2022 |
| 35372719 | A Patient-Level Data Meta-analysis of the Abscopal Effect. | Adv Radiat Oncol | 2022 |
| 35536148 | Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up. | J Urol | 2022 |
| 35536144 | Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management. | J Urol | 2022 |
| 35536141 | Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions. | J Urol | 2022 |
| 35725549 | Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost. | Brachytherapy | 2022 |
| 36483055 | Correlation of an Electronic Geriatric Assessment With Receipt of Adjuvant Radiation and Chemotherapy in Older Adults With Head and Neck Cancer. | Adv Radiat Oncol | 2022 |
| 36367724 | Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy. | JAMA Netw Open | 2022 |
| 36034583 | Oligometastatic Squamous Cell Transformation From Metastatic Prostate Adenocarcinoma Treated With Systemic and Focal Therapy: A Case Report. | J Immunother Precis Oncol | 2022 |
| 36115426 | Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation. | Urology | 2022 |
| 35050342 | Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy. | JAMA Oncol | 2022 |
| 35020444 | Dermatological Adverse Events in Prostate Cancer Patients Treated with the Androgen Receptor Inhibitor Apalutamide. | J Urol | 2022 |
| 34756495 | Outcomes following head and neck cancer surgery among older adults as determined by an electronic geriatric assessment. | J Geriatr Oncol | 2022 |
| 34667026 | Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors. | Clin Cancer Res | 2022 |
| 32822275 | Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma. | J Clin Oncol | 2021 |
| 37057447 | Sildenafil Citrate and Risk of Biochemical Recurrence in Prostate Cancer Patients Treated with Radiation Therapy: Post-Hoc Analysis of a Randomized Controlled Trial. | J Sex Med | 2021 |
| 33587971 | Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapy. | Radiother Oncol | 2021 |
| 33586179 | Any day, split halfway: Flexibility in scheduling high-dose cisplatin-A large retrospective review from a high-volume cancer center. | Int J Cancer | 2021 |
| 33753140 | A Multi-Institutional Phase 2 Trial of High-Dose SAbR for Prostate Cancer Using Rectal Spacer. | Int J Radiat Oncol Biol Phys | 2021 |
| 33606323 | Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy. | Head Neck | 2021 |
| 34617275 | Current considerations for radiotherapy in HPV-associated head and neck cancer. | J Surg Oncol | 2021 |
| 34588146 | Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer. | Brachytherapy | 2021 |
| 34381934 | <i>TERT</i> Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence. | JCO Precis Oncol | 2021 |
| 34585792 | The effect of short radiation treatment breaks on chemo-radiotherapy for oropharyngeal cancers. | Head Neck | 2021 |
| 33941352 | In Regard to Zietman. | Pract Radiat Oncol | 2021 |
| 34293201 | Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial. | Cancer | 2021 |
| 34143193 | Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy. | JAMA Netw Open | 2021 |
| 33429428 | Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial. | J Natl Cancer Inst | 2021 |
| 33107986 | Case study of the integration of electronic patient-reported outcomes as standard of care in a head and neck oncology practice: Obstacles and opportunities. | Cancer | 2021 |
| 30892716 | Patterns of Radiotherapy Use and Outcomes in Head and Neck Soft-Tissue Sarcoma in a National Cohort. | Laryngoscope | 2020 |
| 33665486 | Urinary Outcomes for Men With High Baseline International Prostate Symptom Scores Treated With Prostate SBRT. | Adv Radiat Oncol | 2020 |
| 31668713 | Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer. | Eur Urol Oncol | 2020 |
| 32097507 | Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies. | Cancer | 2020 |
| 31944224 | Surveillance Outcomes and Intensity of Salvage Therapy Among Human Papillomavirus-Associated Oropharyngeal Cancers. | JAMA Otolaryngol Head Neck Surg | 2020 |
| 31678634 | A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma. | Int J Radiat Oncol Biol Phys | 2020 |
| 33145460 | Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19. | Adv Radiat Oncol | 2020 |
| 33305082 | Clinical Outcomes of Combined Prostate- and Metastasis-Directed Radiation Therapy for the Treatment of De Novo Oligometastatic Prostate Cancer. | Adv Radiat Oncol | 2020 |
| 33066781 | Strict bladder filling and rectal emptying during prostate SBRT: Does it make a dosimetric or clinical difference? | Radiat Oncol | 2020 |
| 32997577 | Role of Androgen-Deprivation Therapy Remains Uncertain for Intermediate-Risk Patients When Using Dose-Escalated Radiotherapy. | J Clin Oncol | 2020 |